|
|
On
September 30, 2004, the international prescription
drug company Merck announced the worldwide withdrawal
of the arthritis medication Rofecoxib, sold
in most countries under the brand name Vioxx,
because a study showed an increased risk of
heart attack and stroke. Patients who have suffered
injuries due to Vioxx have filed litigation
against Merck for failing to recall the drug
when it first learned of Vioxx's dangerous side
effects.
To contact in confidence an experienced personal
injury attorney at Lieff Cabraser working on
the Vioxx lawsuit, click
here. |
|
|
|
|
|
The
painkiller Vioxx was marketed throughout the
world, sold in many countries under the name
Vioxx and in others as Ceoxx. Lieff Cabraser
is working with attorneys and solicitors in:
Argentina
 Austria
Canada
Ireland
Italy
South Africa
United
Kingdom
and other countries to bring litigation against
Merck in U.S. courts for patients suffering
heart attacks and strokes from Vioxx. If you
are visiting this website from outside the U.S.,
please click here
to contact an attorney regarding your experiences
with Vioxx or Ceoxx. |
|
|
|
| |
|
Our
Offices
|
| |
San
Francisco
Embarcadero Center West
275 Battery Street, Suite 3000
San Francisco, CA
Tel.
Fax.
Map/Directions
|
|
| |
|
|
|
New
York
780 Third Avenue, 48th Floor
New York, NY
Tel.
Fax.
Map/Directions
|
| |
|
Washington
D.C.
1100 New York Ave., N.W.
Suite 1080 - West Tower
Washington, DC
Tel.
Fax.
Map/Directions
|
|
|
|
|
|
|
Beverly
Hills
9401 Wilshire Boulevard
Twelfth Floor
Beverly Hills, CA
Tel.
Fax.
Map/Directions
|
| |
|
Nashville
3319 West End Ave., Ste 600
Nashville, TN
Tel.
Fax.
Map/Directions
|
 |
|
|
|
|
|
Lieff
Cabraser Heimann & Bernstein, LLP
|
|
|
|
|
|
|
| Trademark
Notice |
| "Vioxx"
is a registered trademark of Merck. Lieff Cabraser Heimann
& Bernstein, LLP is in no way affiliated with Merck,
and the Vioxx trademark is used solely for informational
purposes. |
|
|
|
Copyright
© 2004-2005 Lieff Cabraser Heimann & Bernstein,
LLP
|
| |
|
|
"Banned
Report on Vioxx Published" Los Angeles
Times, Jan. 25, 2005
A report on Vioxx risks previously blocked by
the FDA was published online Monday after the
agency withdrew its opposition. The study found
that as many as 140,000 cases of heart disease
in the United States and as many as 56,000 deaths
were caused by the painkiller Vioxx during the
five years that it was on the market.
To read more press articles on the Vioxx recall
and Vioxx class action lawsuit, click
here. |
|
|
|
|
|
| Lieff
Cabraser has participated in twenty-three $100
million-plus settlements and verdicts. To read
a summary, click here. |
|
|
|
|
|
Click here to read
recent press articles on the Vioxx recall and
Vioxx lawsuits. |
|
|
|
|
|
Read about key events in the Vioxx recall and
Vioxx lawsuit by clicking
here. |
|
|
|
|